Marlowe Share Discussion Threads

[wad collector] 08/9/2021 10:29

CEO buy 2 weeks ago was pointed out in Telegraph and repeated in the Week as their newsworthy director deal of week, though not a huge buy at 802p.

[wad collector] 04/9/2021 22:06

As a holder in both Marlowe and Restore I have watched bid events with a kind of detachment , I wonder what happens next...

[1nf3rn0] 15/8/2021 18:47

I see Berenberg issued a buy note on Friday with a 1160p target, previous target 900p.With current number of shares in issue that'd be a valuation of 9 times company projected EBITDA of £100M in 2024.

[sogoesit] 10/8/2021 07:26

Yes, hopefully onwards then upwards again.

[dr biotech] 10/8/2021 07:15

I’m glad to see they’ve pulled out of the bid. Management have done well here so we can forgive this mistake, hope it’s not too costly in terms of spent fees.

[masurenguy] 07/8/2021 10:07

Took profits and exited here during the week so I won't be updating this thread in the future. GLA

[sogoesit] 06/8/2021 17:30

Overreach for sure if not illogical.
Let's hope management receive the message from the market loud and clear and act accordingly.

[davr0s] 03/8/2021 19:37

I am a holder but this recent acquisition attempt seems to be a case study on how not to do it IMO

[1nf3rn0] 29/7/2021 10:37

How does API Group takeover of Chubb affect growth potential for Marlowe? Chubb have a large UK fire and security presence and API bring other safety offerings they can cross sell.https://ir.apigroupcorp.com/presentations

[dr biotech] 23/7/2021 13:52

Looks like the market thinks this is a bad idea. As the share price plummmets it makes the chances of the mostly paper bid drop too.

[pyemckay] 22/7/2021 11:23

the ceo at Marlowe is ex - restore . make of that what you will.

[dr biotech] 22/7/2021 07:57

Not sure that taking on huge acquisitions is the way forward here. Going directly to shareholders with board recommendations is difficult too. Do we need the distraction?

[dr biotech] 10/5/2021 09:01

Ahead of consensus, looks like things are going to plan and this continues its steady climb. More bolt on acquisitions today too.

[essential] 10/5/2021 08:57

Under the radar share this one. Scsw like it too

[masurenguy] 22/2/2021 18:15

Marlowe growth plans to drive shares, says Berenberg

Security systems provider Marlowe has set out ‘highly ambitious’ growth targets that Berenberg says could deliver serious upside. Analyst Calum Battersby reiterated his ‘buy’ recommendation and increased the target price from 660p to 900p. The company has announced targets over the next 3 years, including hitting £500m of revenue and £100m of earnings to be achieved ‘through a combination of 7% of organic growth per annum, 20% margins, 90% cash conversion and continuation of the group’s existing M&A strategy’, according to Battersby. ‘While clearly an aggressive target, we believe this can be achieved, given the company’s track record to date, and the scale of opportunities that already exist in its various end-markets,’ he said.

[dr biotech] 17/2/2021 07:11

Decent enough update, higher targets and trading towards the top end of forecasts. Always going to be a relatively slow burner

[masurenguy] 20/11/2020 07:14

20 November 2020

Completion of Refinancing

Marlowe plc announces that has signed a new, enlarged revolving credit facility with HSBC UK Bank PLC and National Westminster Bank PLC. The new facility replaces the Group's existing GBP45 million facility and comprises a three-year, £70m revolving credit facility and an additional accordion facility of £20m. The enlarged debt facility will provide further resources to support the Group's ongoing targeted acquisition strategy.

The Group will publish Half Year results for the period ended 30 September 2020 on 3 December 2020.

[masurenguy] 02/11/2020 07:12

Another brick in the wall !

Acquisition of Black & Banton Occupational and Physical Health Limited

Marlowe plc ("Marlowe" or the "Group"), the specialist services group focused on developing companies which assure safety and regulatory compliance, announces that it has acquired Black & Banton Occupational and Physical Health Limited ("Black & Banton") for an initial consideration of £1.1m.

Black & Banton, established in 2001, is headquartered in Gateshead, Tyne and Wear, and provides occupational health services to businesses in the North of England and Scotland. For the year ended 30 April 2020, Black & Banton generated profit before tax of £0.4m on revenues of £1.7m. Net assets at 30 April 2020 were £0.9m. The total enterprise value of up to £1.5mn includes a contingent cash earn-out of up to £0.4m. The acquisition will be funded from Marlowe's existing cash resources.

[energeticbacker] 29/10/2020 18:25

Investor's Champion comments "The consideration paid for acquisitions is clearly not the true cost given the significant subsequent restructuring costs incurred, with £6.7m in 2020."

[dr biotech] 29/10/2020 09:02

(Edit) paid 60m for a company that make 4.4m. Not a bargain, but seems a strategic fit.

Placing at current share price always a sign of confidence. I

[masurenguy] 29/10/2020 08:03

28 October 2020
Marlowe plc

Acquisition of Ellis Whittam (Holdings) Limited

Marlowe plc, the specialist services group focused on developing companies which assure safety and regulatory compliance, announces that it has entered into a conditional agreement to acquire Ellis Whittam (Holdings) Ltd (together with its subsidiaries) for consideration of £59m on a cash-free, debt-free basis. Founded in 2004, Ellis Whittam is one of the UK's leading providers of outsourced Employment Law, HR and Health & Safety services. The company provides its services via a fixed-fee subscription model to over 3,300 organisations across the UK. It is headquartered in Chester, with offices in Glasgow and London, and employs approximately 180 staff, more than half of whom are health & safety consultants, employment lawyers and HR compliance advisors. Ellis Whittam's subscription-based advisory services help employers across the UK remain compliant with evolving employment law and health & safety legislation.

The Group also announces a proposed placing to raise gross proceeds of up to £30m through the issue of up to 5,441,376 new ordinary shares of 50 pence each (the "Placing Shares") at 547p per share (the "Placing Price") to new and existing investors (the "Placing"). The Placing will be conducted by way of an accelerated bookbuild process which will be launched immediately in accordance with the terms and conditions set out in the Appendix to this Announcement.
...........................................................................................................................................
.
29 October 2020
Marlowe plc

Results of the Placing

Further to the announcement of 28 October 2020 of the acquisition of Ellis Whittam and a proposed placing, Marlowe announces that it has successfully raised approximately £30m before expenses under the Placing, which was oversubscribed. The Placing Price of 547p per share represents a nil discount to the closing price on 28 October 2020.

A total of 5,441,376 Placing Shares were placed with institutional investors, conditional on Admission. Pursuant to the Placing, the Group has raised net proceeds of approximately £29m after expenses. The issue of the Placing Shares is not subject to shareholder approval. Application has been made for the 5,441,376 Placing Shares to be admitted to trading on AIM, and it is expected that Admission will occur at 8.00 a.m. on or around 3 November 2020. Therefore, following Admission of the Placing Shares, the total number of Ordinary Shares with voting rights in the Group will be 60,266,796, which may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Group under the FCA's Disclosure Guidance and Transparency Rules.

[jimpetebobbez1] 12/10/2020 10:59

Great - many thanks for confirming

[dr biotech] 12/10/2020 10:52

Small company share watch. It’s a decent journal.

[jimpetebobbez1] 12/10/2020 10:11

Hi, which tip sheet were they mentioned on?

[dr biotech] 05/10/2020 11:57

I bought these on the back of a share tip sheet. Its interesting to see the number of trades today so far is 34. Last week there were typically between 5-15 trades a day, gives an idea how many of us are reading and following this publication. I guess you'd have to look after a few days for a real figure. But I did notice this was marked up on opening to make sure we all paid a few quid extra.